Cargando…
Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
Burkholderia pseudomallei, a bacterium that causes the disease melioidosis, is intrinsically resistant to many antibiotics. First-line antibiotic therapy for treating melioidosis is usually the synthetic β-lactam, ceftazidime (CAZ), as almost all B. pseudomallei strains are susceptible to this drug....
Autores principales: | Sarovich, Derek S, Price, Erin P, Limmathurotsakul, Direk, Cook, James M, Von Schulze, Alex T, Wolken, Spenser R, Keim, Paul, Peacock, Sharon J, Pearson, Talima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430440/ https://www.ncbi.nlm.nih.gov/pubmed/22977307 http://dx.doi.org/10.2147/IDR.S35529 |
Ejemplares similares
-
Characterization of Ceftazidime Resistance Mechanisms in Clinical Isolates of Burkholderia pseudomallei from Australia
por: Sarovich, Derek S., et al.
Publicado: (2012) -
Within-Host Evolution of Burkholderia pseudomallei in Four Cases of Acute Melioidosis
por: Price, Erin P., et al.
Publicado: (2010) -
Burkholderia pseudomallei distribution in Australasia is linked to paleogeographic and anthropogenic history
por: Baker, Anthony L., et al.
Publicado: (2018) -
Microevolution of Burkholderia pseudomallei during an Acute Infection
por: Limmathurotsakul, Direk, et al.
Publicado: (2014) -
Pan-drug-resistant and biofilm-producing strain of Burkholderia pseudomallei: first report of melioidosis from a diabetic patient in Yogyakarta, Indonesia [Letter]
por: Dance, David AB, et al.
Publicado: (2019)